Literature DB >> 638081

Immunologic characterization and quantification of haemoglobin A1c.

J Javid, P K Pettis, R J Koenig, A Cerami.   

Abstract

Sheep antiserum developed against the human glycohaemoglobin, Hb A1c, distinguishes this fraction from the major component Hb A0. Partial cross reactivity is observed with Hb A1a and Hb A1b, as well as with analogous glycohaemoglobins from mouse and dog haemolysates. The reactivity of the haemoglobins with this specific antiserum is abolished by the reduction of the keto group of the sugar ligand. The immunological specificity displayed provides the basis of a quantitative assay for Hb A1c, suitable for studies of clinical and experimental diabetes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638081     DOI: 10.1111/j.1365-2141.1978.tb01051.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  HbA1c standardisation destination--global IFCC Standardisation. How, why, where and when--a tortuous pathway from kit manufacturers, via inter-laboratory lyophilized and whole blood comparisons to designated national comparison schemes.

Authors:  Ian Goodall
Journal:  Clin Biochem Rev       Date:  2005-02

Review 2.  Glycosylated haemoglobin: measurement and clinical use.

Authors:  I Peacock
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

3.  [Routine determination of HB A1 by micro-column technique (author's transl)].

Authors:  T Gain; U Henderkott; P Bottermann
Journal:  Klin Wochenschr       Date:  1981-03-02

4.  A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins.

Authors:  L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

5.  Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon.

Authors:  R L Jones; C M Peterson
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

6.  Acetaldehyde adducts with hemoglobin.

Authors:  V J Stevens; W J Fantl; C B Newman; R V Sims; A Cerami; C M Peterson
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.